Literature DB >> 19210742

Bayesian nonparametric nonproportional hazards survival modeling.

Maria De Iorio1, Wesley O Johnson, Peter Müller, Gary L Rosner.   

Abstract

We develop a dependent Dirichlet process model for survival analysis data. A major feature of the proposed approach is that there is no necessity for resulting survival curve estimates to satisfy the ubiquitous proportional hazards assumption. An illustration based on a cancer clinical trial is given, where survival probabilities for times early in the study are estimated to be lower for those on a high-dose treatment regimen than for those on the low dose treatment, while the reverse is true for later times, possibly due to the toxic effect of the high dose for those who are not as healthy at the beginning of the study.

Entities:  

Mesh:

Year:  2009        PMID: 19210742      PMCID: PMC2748143          DOI: 10.1111/j.1541-0420.2008.01166.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  2 in total

1.  A Bayesian semiparametric accelerated failure time model.

Authors:  S Walker; B K Mallick
Journal:  Biometrics       Date:  1999-06       Impact factor: 2.571

2.  Bayesian monitoring of clinical trials with failure-time endpoints.

Authors:  Gary L Rosner
Journal:  Biometrics       Date:  2005-03       Impact factor: 2.571

  2 in total
  26 in total

1.  A Predictive Study of Dirichlet Process Mixture Models for Curve Fitting.

Authors:  Sara Wade; Stephen G Walker; Sonia Petrone
Journal:  Scand Stat Theory Appl       Date:  2014-09       Impact factor: 1.396

2.  Flexible modeling of the hazard rate and treatment effects in long-term survival studies.

Authors:  Yolanda Hagar; James J Dignam; Vanja Dukic
Journal:  Stat Methods Med Res       Date:  2017-02-02       Impact factor: 3.021

3.  Posterior consistency in conditional distribution estimation.

Authors:  Debdeep Pati; David B Dunson; Surya T Tokdar
Journal:  J Multivar Anal       Date:  2013-04-01       Impact factor: 1.473

4.  Bayesian non-parametric survival regression for optimizing precision dosing of intravenous busulfan in allogeneic stem cell transplantation.

Authors:  Yanxun Xu; Peter F Thall; William Hua; Borje S Andersson
Journal:  J R Stat Soc Ser C Appl Stat       Date:  2018-12-16       Impact factor: 1.864

5.  Bayesian dynamic regression models for interval censored survival data with application to children dental health.

Authors:  Xiaojing Wang; Ming-Hui Chen; Jun Yan
Journal:  Lifetime Data Anal       Date:  2013-02-07       Impact factor: 1.588

6.  A class of mixtures of dependent tail-free processes.

Authors:  A Jara; T E Hanson
Journal:  Biometrika       Date:  2011-09       Impact factor: 2.445

Review 7.  Bayesian local influence for survival models.

Authors:  Joseph G Ibrahim; Hongtu Zhu; Niansheng Tang
Journal:  Lifetime Data Anal       Date:  2010-06-06       Impact factor: 1.588

8.  Bayesian nonparametric estimation of targeted agent effects on biomarker change to predict clinical outcome.

Authors:  Rebecca Graziani; Michele Guindani; Peter F Thall
Journal:  Biometrics       Date:  2014-10-15       Impact factor: 2.571

9.  Bayesian inference for longitudinal data with non-parametric treatment effects.

Authors:  Peter Müller; Fernando A Quintana; Gary L Rosner; Michael L Maitland
Journal:  Biostatistics       Date:  2013-11-26       Impact factor: 5.899

10.  Bayesian Nonparametric Inference - Why and How.

Authors:  Peter Müller; Riten Mitra
Journal:  Bayesian Anal       Date:  2013       Impact factor: 3.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.